These results imply that RhoGDIβ overexpression inhibits miR‐200c abundance, which results in promoting JNK2 protein translation and subsequently upregulating Sp1 activity and mmp‐2 transcription, as well as promoting BC cell invasion. The gene discussed is SP1; the disease is breast cancer.